Shipping gets smarter; Potent compound certification;

> SenseAware--an information service that combines a GPS sensor device and Internet-based collaboration platform for life sciences supply chain management--will be unveiled next spring by FedEx. Item

> API maker ScinoPharm has received the Potent Compound Safety Certification from SafeBridge Consultants for portions of its Tainan, Taiwan, facility. Release

> French drug maker Servier has cut the ribbon on a 4,500 square meter $70.3 million manufacturing plant in Ireland. Item

> Thyroid drug Thyrolar is in short supply as the manufacturer scrambles to satisfy a U.S. Pharmacopeia mandate for new specs for one of the drug's components, says Forest Labs. Article

> MdBio Foundation has sold its BioProcessing Center manufacturing facility in Baltimore to Emergent BioSolutions for $7.85 million.  Release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.